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Although it is well-established that b1 integrins play a functional role in the migration of cranial neural crest cells, little
is known about the number or importance of their associated a subunits. Here, we have utilized antisense oligonucleotides
(aONs) against various mammalian integrin a subunits to functionally ``knock out'' integrins in vitro and in vivo. First,
we examined the attachment in vitro of cranial neural crest cells to ®bronectin and laminin in the presence of antisense
or reversed-sense oligonucleotides using a quantitative adhesion assay. We found three a integrin aONs that blocked
attachment to ®bronectin substrates only, one that blocked attachment to laminin substrates only, and one that blocked
attachment to both ®bronectin and laminin. As expected, an aON to chick b1 integrin reduced attachment to both ®bronec-
tin and laminin substrates. These results suggest that there are three or more functionally distinct integrin heterodimers
on avian cranial neural crest cells. Second, we examined the ability of aONs against various a integrin subunits to perturb
cranial neural crest migration in vivo by injecting the oligonucleotides into the cranial mesenchyme through which neural
crest cells migrate. Those a aONs that inhibited cell attachment in vitro also caused neural crest and/or neural tube
abnormalities after injection in vivo. In addition, two aONs that had no effect in vitro did affect emigration of neural crest
cells in vivo. Immunoprecipitations revealed that some integrin subunits were depleted after treatment with antisense but
not reversed-sense oligonucleotides both in vivo and in vitro. The results suggest that integrin a subunits are required for
cranial neural crest cell attachment and emigration. q 1996 Academic Press, Inc.
INTRODUCTION of neural crest cell attachment to these ECM molecules
(Lallier and Bronner-Fraser, 1991).
In the avian embryo, cranial neural crest cells are a partic-Integrins are thought to be the primary mediators of cell±
ularly good model system for studying the function of inte-matrix interactions in the embryo, functioning as receptors
grins in cell migration in vivo because the head region offor extracellular matrix (ECM) molecules including ®bro-
the embryo is easily accessible to blocking reagents thatnectin, laminin, vitronectin, tenascin, and various collagens
disrupt cell±matrix interactions. Microinjection of antibod-(Horwitz et al., 1985; Buck et al., 1986; Tomaselli et al.,
ies lateral to the cranial neural tube in vivo can functionally1988; Bourdon and Ruoslahti, 1989). Because neural crest
perturb selected cell±matrix interactions along neural crestcells undergo extensive migrations along pathways lined
migratory pathways. This approach has shown that the inte-with ECM molecules including ®bronectin (Newgreen and
grin b1 subunit, ®bronectin, laminin±heparan sulfate pro-Thiery, 1980), laminin (Krotoski et al., 1986), tenascin/cyto-
teoglycan complex, tenascin, N-CAM, N-cadherin, and ga-tactin (Tan et al., 1987), and various collagens (Duband and
lactosyltransferase are necessary for proper emigration ofThiery, 1987; Perris et al., 1991), they represent a good
cranial neural crest cells (Bronner-Fraser, 1985, 1986; Poolemodel system for studying the function of integrins during
and Thiery, 1986; Bronner-Fraser and Lallier, 1988; Runyandevelopment. In vitro, antibodies against b1-integrins block
et al., 1986; Bronner-Fraser et al., 1992). The b1 subunittrunk neural crest attachment to ®bronectin, laminin, and
of integrin has been detected throughout developing aviancollagens, suggesting that they are the primary mediators
(Duband et al., 1986; Krotoski et al., 1986), murine (Suther-
land et al., 1993), and amphibian embryo (Gawantka et al.,
1994). It pairs with numerous a subunits and these hetero-1 To whom correspondence should be addressed. Fax: (714) 824-
4709. dimers are thought to represent one of the major ECM recep-
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ilton, 1951), before cranial neural crest emigrate from the neuraltor families in the early embryo. In contrast to the b1 sub-
tube. The midbrain region of these embryos was dissected in How-unit, considerably less is known about the a integrin sub-
ard Ringer's solution using a tungsten needle. Neural folds wereunits that affect migration and attachment of cranial neural
then excised and explanted onto a ®bronectin (25 mg/ml)-coatedcrest cells.
35-mm petri dish and incubated at 377C. After 1 hr, 1.5 ml ofWhich integrins mediate interactions between neural
culture medium [modi®ed Eagle's medium (MEM; Gibco) supple-
crest cells and extracellular matrix molecules? a1 (Lallier mented with 15% horse serum (Gibco) and 10% 11-day chick em-
and Bronner-Fraser, 1992), av (Delannet et al., 1994), and a4 bryo extract] was added to the ®bronectin-coated plates. A mono-
(Stepp et al., 1994) subunits have been described on some layer of cranial crest cell emigrated from the explanted neural folds
populations of trunk neural crest cells, with functional evi- within a few hours of explantation. These cranial neural crest cells
were distinguished from other cell types by their distinct stellatedence for involvement in in vitro adhesion to laminin and
morphology.vitronectin for a1 and av , respectively. To characterize other
a subunits used by trunk neural crest cells in vitro, short
antisense phosphorothioated oligonucleotides (15- to 30-
Preparation of Cells for Attachment Assaysmers) have been used to knock out mRNA for proteins in
cultured cells (Lallier and Bronner-Fraser, 1993). Short anti- Within a few hours of explantation, the cranial neural crest cul-
ture was labeled with [3,4-3H]leucine (10±50 mCi/ml) from Amer-sense oligonucleotides are taken up by a large percentage
sham for 16 hr. To block nonspeci®c adhesion, cultures were rinsedof cells and block transcription and/or translation of the
®ve times with MEM containing 10 mg/ml BSA (bMEM). Thentarget DNA (Caceres et al., 1990). Based on substratum-
cells were incubated with 5 mM EDTA in bMEM for 10 min atselective inhibition of cell attachment, we found that at
377C which releases them from ®bronectin-coated plates. Cellsleast three distinct a integrin subunits were functional on
were collected by centrifugation at 2000 rpm and used immediately
trunk neural crest cells (Lallier and Bronner-Fraser, 1993). in the cell attachment assay.
The types of integrins possessed by trunk and cranial neu-
ral crest cells appear to differ (Lallier and Bronner-Fraser,
1992). For example, injection of b1 integrin antibodies into Oligonucleotides
trunk levels has no effect on neural crest migration, though
Reversed-sense and antisense phosphorothioated oligonucleo-these antibodies do alter migration of myoblasts (Jaffredo
tides (Table 1) were made utilizing the same sequences described
et al., 1988). Furthermore, trunk neural crest cells adhere by Lallier and Bronner-Fraser (1993), which were designed to inhibit
to collagen, whereas cranial neural crest cells do not (Lallier the production of the b1 and various a subunits. These phosphoro-
and Bronner-Fraser, 1992). Such differences between cranial thioate-modi®ed oligonucleotides have increased stability: they
and trunk neural crest cells support the idea that these pop- have a half-life of greater than 1 hr compared to the half-life of
ulations have divergent adhesive interactions. unmodi®ed oligonucleotides which is less than 5 min (Akhtar et
al., 1991). The antisense oligonucleotide directed to the b1 integrinIn contrast to the trunk region, virtually nothing is
subunit (cb1) encompasses nucleotides 1630 to 1648 of chick b1,known about the a subunits present on cranial neural crest
a region of high similarity to b1 subunits from other species butcells in vitro or in vivo, despite the fact that in vivo pertur-
low similarity to other b subunits. Due to the lack of sequencebation experiments only have been successful on cranial
information for avian a subunits, ``guessmer'' sequences were se-neural crest cells. Here, we used antisense oligonucleotides
lected from known sequences from human or rat integrins (Lallier
(aONs) designed against various integrin a and b1 subunits and Bronner-Fraser, 1993). Since they were selected based on nucle-
to ``knock out'' integrins on cranial neural crest cells both otide sequence information from other species, these oligonucleo-
in vitro and in vivo. These reagents are useful because there tides do not necessarily correspond to the same a subunits in avian
is a paucity of blocking antibodies available for individual integrins, for which sequences are currently unavailable. Oligonu-
avian integrins. First, we examined the attachment of cra- cleotides ha4-1 through ha4-2 were selected from regions of highest
nucleotide sequence identity among published integrin a subunits.nial neural crest cells to ®bronectin and laminin in the
Other antisense oligonucleotides (ra1-1 through ha5) were designedpresence of antisense or control oligonucleotides using a
from sequence data available for individual human or rat a subunitsquantitative adhesion assay. Second, we examined the abil-
(a1 , a4 , and a5). For in vitro cell attachment assay, an oligonucleo-ity of antisense oligonucleotides against various a integrin
tide concentration of 100 mM was chosen based on a dose±responsesubunits to perturb cranial neural crest migration in vivo.
test (range  25 to 200 mM ). Greatest inhibition was observed at
By combining functional assays in vitro and in vivo with 100 mM without ill effects from oligonucleotide toxicity. For in
biochemical characterization, the results show that integrin vivo studies, an oligonucleotide concentration of 3 mM was used
a subunits are required for cranial neural crest cell attach- because this represented the minimum concentration tested (range
ment and emigration.  1 to 10 mM ) which caused a detectable phenotype.
Cell Attachment AssayMATERIAL AND METHODS
Attachment of cranial neural crest cells to ®bronectin and lami-Primary Cranial Neural Crest Cell Cultures
nin substrata in the presence of various oligonucleotides was mea-
sured by a centrifugal adhesion assay described by McClay et al.Japanese quail embryos were incubated at 387C until they
reached stage 8±9 (according to the criteria of Hamburger and Ham- (1981) as described (Lallier and Bronner-Fraser, 1991, 1992). Fibro-
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nectin (40 mg/ml) and laminin (20 mg/ml) were adsorbed for 12 hr a carbohydrate epitope on neural crest cells (Bronner-Fraser, 1986).
These sections were rinsed in 10 mM PBS with 0.9% NaCl andat 257C onto polyvinyl chloride microtiter plates. Wells were
washed with bMEM and incubated with bMEM for 2 hr at 257C. incubated with ¯uorescein-conjugated secondary antibody against
mouse IgM for 1 hr at 257C. Mounting medium was placed overWells then were washed and 50 ml of labeled cells and oligonucleo-
tides was added to a ®nal concentration of 100 mM. The plates the sections prior to attaching a coverslip.
then were incubated for 6 hr at 377C. Cells were added to the wells
and constant centrifugal force of 150g for 5 min was applied to Immunoprecipitation of b1 Integrin
bring the cells in contact with the substrata. The chamber then In vitro. To determine that the inhibitions observed in the cen-
was sealed and incubated for 15 min at 257C and the unbound cells trifugal cell adhesion assay were associated with reductions in the
were removed by applying a centrifugal force of 50g for 5 min. The amounts of integrin proteins, immunoprecipitations were per-
chambers were quickly frozen in a methanol/dry ice bath. The formed on cranial neural crest cells. Primary cranial neural crest
unbound and bound cells were removed and placed in separate cultures were prepared as described above and treated with integrin
scintillation vials. The samples were analyzed for [3,4-3H]leucine
b1 antisense oligonucleotides at 100 mM concentration for 6 hr.radioactivity using a scintillation counter. The percentage of bound The cells were released from ®bronectin-coated plates by incuba-
neural crest cells per well was determined as tion with 5 mM EDTA. Then, surface proteins were biotinylated
with 0.1 mg/ml NHS-LS-Biotin from Pierce in 10 mM PBS with
% cell bound  % cts min01 bound 0.9% NaCl at 377C for 1 hr. Cells were washed for four times.
Surface biotinylated cells were solubilized by trituration in 1 ml
solubilizing buffer [100 mM NaCl, 1% NP-40, 0.5% SDS, 2 mM cts min
01 bound 1 100%
Total cts min01 (bound / unbound) . PMSF (phenylmethylsulfonyl ¯uoride), 50 mM Tris, pH 7.5] and
incubated at 47C for 10 min. Extracts were centrifuged (14,000g for
Data points represent the standard error of the mean (SEM) for 5 min) to remove debris and precleared by incubation with 20 ml
six wells within one experiment; each experiment was repeated at goat anti-mouse IgG coupled to Sepharose (Sigma) at 47C for 20
least three times. Values for percentage of inhibition were deemed min with agitation. Sepharose beads were removed by centrifuga-
signi®cantly different when the P value, determined by Student's tion, and the supernatants were incubated with the anti-b1 mono-
one-sided t test, was 0.05. clonal antibody JG22 (from Developmental Studies Hybridoma
Bank; diluted 1:200 from ascites ¯uid) overnight with agitation
at 47C. Twenty-®ve milliliters of goat anti-mouse IgG coupled to
Sepharose was added to each sample and allowed to incubate for 1Microinjection of Antisense Oligonucleotide onto
hr at 47C with agitation. The Sepharose beads were separated byCranial Neural Crest Pathways in Vivo
centrifugation and washed ®ve times with 0.51 solubilizing buffer
To examine the role of integrins in cranial crest migration in at 47C. The resulting samples were separated by SDS±PAGE. Eight
vivo, White Leghorn chicken embryos at Hamburger and Hamilton percent acrylamide gels were chosen to give optimal separation of
stage 8±9 were injected with reversed-sense or antisense oligonu- proteins with Mr in the range of 250,000 to 50,000. The proteins
cleotides to integrin a and b1 subunits. The eggs were washed with were electrophoretically separated utilizing the buffer system de-
70% ethanol and a window was made over the embryo. India ink scribed by Laemmli (1970) and electrophoretically transferred to
was injected under the blastoderm to aid in visualization of the nitrocellulose membranes (Burnette, 1981). Membranes were
embryo. The vitelline membrane over the injection site was re- blocked in 5% BSA/2% nonfat dry milk in TBST (Tris±saline
moved and a micromanipulator was used to position a glass micro- buffer; 10 mM Tris, pH 7.4; 150 mM NaCl, 0.5% Tween 20) over-
pipet that was back®lled with 3 mM antisense oligonucleotide in night at 47C and probed with horseradish peroxidase conjugated to
10 mM Tris.Cl, 1 mM EDTA, pH 8.0 (Tris±EDTA), buffer. The 0.2 mg/ml streptavidin (Amersham) for 1 hr at 257C. Membranes
antisense oligonucleotides were injected into the mesenchyme lat- were then washed in three changes of TBST and the biotin-labeled
eral to the mesencephalon on both sides of the embryos. Due to proteins were detected by chemiluminescence (ECL, Amersham)
the small size of the antisense oligonucleotides, they freely cross on X-ray ®lm (XAR-5, Kodak). Immunoprecipitations were repeated
the midline. Therefore, we injected bilaterally to maximize the three times with similar results.
concentration of aON within the head region. Injected embryos In vivo. To test if the abnormalities observed in the microinjec-
were sealed with adhesive tape and placed in a 377C incubator for tion experiments in vivo were associated with reductions in inte-
18±24 hr. grin protein expression, immunoprecipitations were performed.
White Leghorn chicken embryos at Hamburger and Hamilton stage
8±9 were injected with oligonucleotides, as described above. The
Histological Procedures injected embryos were incubated for 6 hr at 377C. After incubation,
heads of these embryos were removed and trypsinized in 1% trypsin
After 18±24 hr of incubation, the embryos were collected and
for 10 min. The tissues were triturated, and the cells were collected
®xed in Zenker's ®xative for 1.5 hr. Embryos were then dehydrated,
and biotinylated as above. Because the tissue was triturated, both
embedded in paraf®n, and serially sectioned at a thickness of 10
cell surface and intracellular proteins may be biotinylated by this
m using a Leitz microtome.
procedure. The immunoprecipitation and visualization of proteins
were performed as described for the in vitro experiments.
Immunocytochemistry
RESULTS
To analyze the effects of injecting oligonucleotides against vari-
Previously, we showed that short phosphothioate-modi-ous integrin a subunits, slides of serially sectioned embryos were
incubated overnight at 47C with HNK-1 antibody, which recognizes ®ed oligonucleotides against b1 and various integrin a sub-
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TABLE 1
Antisense Oligonucleotides
Name Sequence Strand Size Location (bases)
b1
cb1 5*-GCAGTAAGCATCCATATC-3* Antisense 18 1630±1648 (chick b1)
Rcb1 3*-GATATGGATGCTTACTGC-5* Sense 18 1630±1648 (chick b1)
Conserved a sequences
ha1 5*-TTGAAGAAGCCAAGCTT-3* Antisense 17 3042±3059 (human a4)
Rha4-1 5*-AACTTCTTCGGTTCGAA-3* Reversed sense 17 3042±3059 (human a4)
ha4-2 5*-GGGTGCCCCCATGAGGA-3* Antisense 17 1009±1026 (human a4)
Rha4-2 5*-CCCACGGGGGTACTCCT-3* Reversed sense 16 1009±1026 (human a4)
Nonconserved a sequences
ra1-1 5*-AAACCTTGTCTGATTCACAGC-3* Antisense 21 1500±1521 (rat a1)
ra1-2 5*-GGCAGCGACTGAAATGTGATG-3* Antisense 21 2793±2814 (rat a1)
ra4-3 5*-TACAGACTCAGGATGGCTTAA-3* Antisense 21 1323±1344 (human a4)
ra5 5*-TCCAGAAGCATTGAGGCAGAA-3* Antisense 21 1581±1602 (human a5)
Note. List of antisense oligonucleotides used in the perturbation experiments. Reversed-sense and the antisense oligonucleotide directed
to the b1 integrin subunit (cb1) encompass nucleotides 1630±1648 of chick b1, a region of high similarity to b1 subunits from other
species but low similarity to other b subunits. Oligonucleotides ha4-1 through ha4-2 were selected from regions of highest nucleotide
sequence identity among published integrin a subunits. Other antisense oligonucleotides (ra1-1 through ha5) were designed from nucleotide
sequence data available for individual human or rat a subunits (a1 , a4 , and a5 ).
units can reduce the attachment of trunk neural crest cells ha4-1 to 55% reduction for ha5. Antisense oligonucleotides
ra1-2 and ha4-3 did not signi®cantly alter adhesion to ®-to ®bronection and laminin in vitro (Lallier and Bronner-
Fraser, 1992). Here, we extend this work to the cranial neu- bronectin. Reversed-antisense oligonucleotides to a and b
integrin subunits (Rcb1, Rha4-1, and Rha4-2) had no sig-ral crest, which provides a particularly good model for
studying the role of integrins in cell±matrix interactions ni®cant effects on neural crest attachment.
Attachment to laminin substrates. Several antisensebecause of its accessibility to perturbation both in tissue
culture and in the intact embryo. Oligonucleotide se- oligonucleotides produced signi®cant levels of inhibition of
attachment to laminin substrates (Fig. 1B). Antisense oligo-quences were selected from known sequences of mamma-
lian integrins (Table 1). We used a centrifugal attachment nucleotide cb1, which was directed against the integrin cb1
subunit, produced a 50% decrease in cell attachment toassay to study the adhesion of the cranial neural crest cells
to ®bronectin and laminin substrates after antisense treat- laminin (P  0.03), comparable to its effect on ®bronectin
substrates. Furthermore, ra1-2 and ha5 against integrin ament. In addition, some of the same antisense oligonucleo-
tides were utilized to perturb cranial neural crest migration subunits caused a 50±60% reduction in the attachment of
cranial neural crest cells to laminin (P  0.01 and 0.001,in vivo.
respectively). In contrast, reversed-sense oligonucleotides
(Rcb1, Rha4-1, Rha4-2, and Rha5) had no detectable effects
Effects of Antisense Treatment in Vitro on cranial neural crest cell attachment to laminin.
Taking together the perturbation results on both lamininWe tested the ability of cranial neural crest to adhere
and ®bronectin substrates, antisense oligonucleotides cb1to ®bronectin and laminin substrates in the presence and
and ha5 inhibited adhesion to both ®bronectin and laminin.absence of antisense oligonucleotides.
Oligonucleotides ha4-1, ha4-2, and ra1-1 blocked adhesionAttachment to ®bronectin substrates. Quail cranial
to ®bronectin only, whereas ra1-2 blocked adhesion to lam-neural crest cells were cultured for 2 days and then incu-
inin only. The observation that there are three patterns ofbated in suspension with either antisense or, as controls,
adhesive perturbation suggests that there are a minimumreversed-sense oligonucleotides for 4 to 6 hr at a dose of
of three putative integrin heterodimers on cranial neural100 mM, which gave maximal inhibition without toxicity.
crest cells.Subsequently, cranial neural crest cell attachment to ®bro-
nectin was quantitated using a centrifugal cell adhesion
assay. The results are presented in Fig. 1A. Effects of Injection of Antisense Oligonucleotides
Antisense oligonucleotides cb1, ha4-1, ha4-2, ra1-1, and in Vivo
ha5 signi®cantly reduced cranial neural crest cells attach-
ment to ®bronectin (P  0.04, 0.02, 0.03, and 0.01, respec- Although in vitro studies of neural crest adhesion to sin-
gle substrates have the advantage of evaluating cell behaviortively) relative to reversed-sense oligonucleotide controls.
The percentage of inhibition ranged from 25% reduction for under de®ned conditions, the embryo is a complex system
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FIG. 1. Antisense oligonucleotides reduced attachment of cranial crest cells in a substrate-speci®c manner. Cranial neural crest cell
attachment to ®bronectin (A) or laminin (B) was assayed after treatment with antisense oligonucleotides (solid bars) or reversed-sense
oligonucleotide (hatched bars) for 6 hr. Bars and SEM represent the mean and standard error for six or more experiments. Those antisense
oligonucleotides that yielded signi®cant inhibition of attachment are indicated with an asterisk above the bar. Values for percentage of
inhibition were deemed signi®cantly different from baseline when the P value, determined by Student's one-sided t test, was 0.05.
in which numerous extracellular matrix molecules line malities (Table 2). After exposure to antisense oligonucleo-
tides ha4-1, ra1-1, ra1-2, ha4-3, and ha5, major defects wereneural crest pathways. Thus, an important corollary to tis-
sue culture experiments are parallel manipulations in the noted in 70±100% of the injected embryos. Antisense oligo-
nucleotide ha4-2 caused abnormalities in 55% of the in-embryo. To this end, we microinjected antisense and re-
versed-sense oligonucleotides at a concentration of 3 mM jected embryos, which is notably higher than control levels,
but not as marked as observed with other blocking oligonu-into the mesenchyme lateral to the cranial neural tube of
the chick embryo prior to the onset of neural crest migra- cleotides.
The most prevalent abnormalities in antisense oligonu-tion. One day later, the effects on the pattern of cranial
neural crest migration were assayed by staining serial sec- cleotide-injected embryos were neural defects, including
open and overgrown, abnormally thickened neural tubestions with the HNK-1 antibody, which recognizes a carbo-
hydrate epitope expressed by migrating neural crest cells. (Fig. 2D). Second, numerous embryos contained neural crest
cells within the lumen of the neural tube (Figs. 2B, 2C, andThe results are summarized in Table 2 and Fig. 2.
Embryos injected with antisense oligonucleotides against 2E), as if they did not emigrate properly but rather populated
the interior of the neural tube. Third, ectopic neural crestintegrin a subunits displayed a high percentage of abnor-
TABLE 2
Injection of Integrin Antisense Oligonucleotides in Vivo
NT NC in Ectopic % Nt % Nc
Oligo Total No. Normal defects NT NC % Abnormal defects defects
Rha4-1 28 21 3 1 3 25 11 14
ha4-1 13 0 7 5 1 100 54 46
Rha4-2 15 10 3 1 1 33 20 13
ha4-2 20 9 5 4 2 55 25 30
ha4-3 14 2 9 0 3 79 64 15
ra1-1 16 4 8 0 4 75 50 25
ra1-2 23 7 9 3 4 70 40 30
ha5 14 2 5 5 2 86 35 51
Note. Summary of in vivo antisense oligonucleotide perturbation experiments. Reversed-sense or antisense oligonucleotides were
injected into the mesenchyme lateral to the mesencephalon of 6±9 somite stage embryos, which then were ®xed 18±24 hr after injection.
Three types of defects were observed: neural tube (NT) defects, neural crest (NC) cells in the lumen of the neural tube, and ectopic neural
crest cell.
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cells were observed outside of the neural tube (Figs. 2C and subunit. Treatment with cb1 led to a decrease in all three
bands by 82, 38, and 79%, respectively, when compared2F); in this case, neural crest cells emigrated from the neural
tube but did not ®nd their proper pathway and often were with untreated cells or Rha4-1-treated cells. Because b1 pro-
tein appears to be the only b subunit on cranial neural crestfound external to the embryo. Other neural crest cells in
these embryos did migrate along their normal pathways, cells, one would expect that a depletion of this subunit
would lead to a corresponding diminution of all ab hetero-indicating that the oligonucleotides affected only a subpop-
ulation of the cells. dimers. In contrast, ha4-1 led to a selective depletion of
the 180-kDa band. Densitometry scans showing the relativeUnlike the antisense oligonucleotides against a subunits,
cb1 against the integrin b1 subunit had no apparent effect on intensity of the bands are shown in Fig. 3C.
In vivo. Because the in vivo environment contains nu-neural crest migration in vivo (n  16; data not shown). This
may be due to the apparently rapid turnover of this subunit merous cell types and is much more complex than that of
isolated neural crest cells in vitro, parallel immunoprecipi-on embryonic cells (Lallier and Bronner-Fraser, 1993).
When reversed-antisense oligonucleotides were injected tations to those described above were performed in heads
of chick embryos 6 hr after injection of oligonucleotidesalong neural crest migratory pathways, no detectable alter-
ations in neural crest migration were observed above back- cb1, Rcb1, ha4-1, and Ra4-1. Embryonic cells were col-
lected, separated into single cells with light trypsinization,ground levels. Of the 28 embryos injected with Rha4-1 or
the 15 injected with Rha4-2, cranial neural crest cells mi- and trituration, biotinylated, and immunoprecipitated with
an antibody to the integrin b1 subunit. As in the in vitrograted from the neural tube, ventrally underneath the ecto-
derm (Fig. 2A). Although a small percentage of the embryos experiments, three prominent bands were apparent in con-
trols lanes, corresponding to molecular masses of 180, 140,displayed some abnormalities (25±33%, respectively), this
level of defects is comparable to that seen after windowing and 120 kDa. The cb1 oligonucleotide resulted in 64, 66,
and 83% reductions in the 180-, 140-, and 120-kDa bands,eggs and injecting saline into embryos at this stage of devel-
opment (Bronner-Fraser, 1986). whereas the ha4-1 oligonucleotide led to 34, 48, and 66%
reductions in the corresponding bands (Figs. 3B and 3D).
The differences in the pro®les observed in vivo and in vitro
Immunoprecitation of Integrin Protein after are likely due to the fact that there are many more cell
Antisense Treatment types in the embryo, some of which possess integrins. How-
ever, both blocking oligonucleotides clearly affect the levelsAntisense oligonucleotides function by reducing the lev-
of integrins.els of mRNA and/or protein produced. To verify that the
inhibition of neural crest attachment in vitro and defects
in embryonic development in vivo are due to a direct effect
DISCUSSIONof the antisense treatment rather than general toxicity, we
measured the levels of protein immunoprecipitated by
avian b1 integrin antibodies. Because integrins form hetero- In the present study, we have used antisense oligonucleo-
tides to investigate the role of integrin a and b1 subunitsdimers, this procedure precipitates both a and b subunits.
In vitro. To quantitate the effects of antisense oligonu- on cranial neural crest cell attachment to ®bronectin and
laminin in vitro and their migration in vivo. In vitro attach-cleotides on levels of integrin heterodimers, the cell surface
of cranial neural crest cells was biotinylated and immuno- ment assays demonstrated that three a integrin aONs
blocked attachment to ®bronectin substrates only, oneprecipitated with an antibody against the chick b1 after
treatment with oligonucleotides. For these experiments, we blocked attachment to laminin substrates only, and one
blocked attachment to both ®bronectin and laminin. Paral-examined the effects of a subset of the aONs: cb1 or ha4-
1 or reversed-sense Rcb1 or Rha4-1 (Fig. 3A). Three major lel injections of aONs onto cranial neural crest migratory
pathways in intact embryos demonstrated that those aintegrin bands were noted after immunoprecipitation: 180,
140, and 120 kDa. The upper two bands correspond to a aONs that inhibited cell attachment in vitro also caused
neural crest and/or neural tube abnormalities in vivo. Im-subunits, whereas the lower band corresponds to the b1
FIG. 2. Fluorescence photomicrographs of transverse paraf®n sections showing the effects of oligonucleotides on cranial neural crest
migration in embryo ®xed 18±24 hr after injection as observed by HNK-1 staining. Embryos injected with reversed-sense ha4-2 (A) have
normal cranial neural crest migration and neural tube (NT) development; neural crest cells emigrate from dorsal NT and migrate ventrally
underneath the ectoderm. Embryos injected with antisense oligonucleotide ha4-1 (B), ra1-1 (C), and ha4-2 (E) have neural crest cells (NC)
in the lumen of the neural tube (curved arrow) in addition to the normal complement of vagal neural crest cells dorsolateral to the neural
tube. An embryo injected with ra1-1 (D) has neural tube abnormalities, including an open and overgrown neural tube; the arrows indicate
the open edges of the neural tube. Ectopic neural crest cells (straight arrow) migrating outside of the embryo are also observed after
injection of ra1-1 (C) and ra1-2 (F). The embryo pictured in (F) has a neural tube that is deformed. In addition to neural crest cells, the
HNK-1 antibody stains the caudal otic placode (OP), heart (H), and some extraembryonic membranes (EX).
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An antisense oligonucleotide to the b1 integrin subunit,
which was previously found to inhibit trunk neural crest
cell attachment to ECM components (Lallier and Bronner-
Fraser, 1993), reduced the attachment of cranial neural crest
cells to both ®bronectin and laminin substrates. This is
consistent with the idea that the b1 class of integrins are the
primary mediators of cranial neural crest cell attachment to
®bronectin and laminin.
Antisense oligonucleotides to various a subunits had dif-
ferential effects in vitro, inhibiting attachment to ®bronec-
tin, laminin, or both substrates. These results suggest that
cranial neural crest cells possess a minimum of three inte-
grin heterodimers: at least one involved in cell attachment
to ®bronectin only, one involved in attachment to laminin
only, and one that binds both ®bronectin and laminin. This
number represents a lower limit because several different
aONs blocked adhesion to ®bronectin; these may recognize
a single or multiple a subunits.
Numerous antisense oligonucleotides designed to eliminate
speci®c a subunits resulted in abnormalities in cranial neural
crest emigration and/or neural tube formation after injection
in vivo. Neural tube defects included malformations, failure
of closure, and overgrowth. Defects in neural crest emigration
resulted in neural crest cells within the lumen of the neural
tube or in ectopic sites external to the embryo. The combina-
tion of neural tube and neural crest defects indicates that
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the aONs are shifting the balance of adhesions that normally
allows for the emigration of neural crest cells from the neuralFIG. 3. Quanti®cation of integrin proteins after in vitro and in
tube. In the absence of proper cell±matrix interactions, somevivo antisense treatment. (A) Immunoprecipitations with anti-b1
antibodies of cranial neural crest cells biotinylated after treatment neural tube cells may fail to undergo the epithelial±mesen-
with antisense, cb1 or ha4-1, or reversed-sense, Rcb1 or Rha4- chymal interaction that gives rise to a neural crest cell, re-
1, oligonucleotides. Three major integrin bands were noted after sulting in overgrowth and malformations of the neural tube.
immunoprecipitation: 180, 140, and 120 kDa. The upper two bands Other neural crest cells form properly but fail to emigrate
correspond to a subunits, whereas the lower band corresponds to from the neural tube onto their normal pathways. Interest-
the b1 subunit. Treatment with cb1 led to a decrease in all three ingly, some aONs that appeared nonfunctional in vitro did
bands by 82, 38, and 79%, respectively, when compared with un-
cause defects in vivo. There are two possible explanations fortreated cells or Rcb1-treated cells. Treatment with ha4-1 led to a
these results: (1) there may be additional substrates to whichselective depletion of the 180-kDa band. (B) Heads of chick embryos
cranial neural crest cells bind in the embryo and/or (2) there6 hr after oligonucleotides cb1, Rcb1, ha4-1, and Rha4-1 were tritu-
may be additional embryonic cell types that are affected byrated, biotinylated and immunoprecipitated with antibody to the
integrin b1 subunit (JG22). Three prominent bands were noted in the microinjected aONs.
controls lanes corresponding to molecular masses of 180, 140, and Although numerous aONs toa subunits altered cranial neu-
120 kDa. The cb1 oligonucleotide resulted in 64, 66, and 83% ral crest migration, we were surprised to ®nd no apparent
reductions in 180-, 140-, and 120-kDa bands, whereas treatment defects after analogous injections of the aON cb1 directed
with the ha4-1 oligonucleotide led to 34, 48, and 66% decreases against the b1 integrin subunit. A likely explanation for thisin corresponding bands. (C) The relative expression levels of cell negative result is the relatively fast turnover rate predicted
surface integrins shown in (A) were quanti®ed by densitometric
for b1 subunits relative to a subunits. Previously, we observedanalyses of ¯uorograms, using Image Quant Software. (D) The rela-
short temporal effects for anti-b1 oligonucleotides when com-tive expression levels of integrins isolated from embryos injected
pared with anti-a integrin oligonucleotides (Lallier and Bron-with various integrin aONs in (B) were quanti®ed by densitometric
ner-Fraser, 1993). We found that trunk neural crest cells recov-analyses of the original ¯uorograms.
ered their adhesivity to ECM components 8 hr after treatment
with anti-b1, but only 16 hr after treatment with anti-a inte-
grin oligonucleotides. Because embryos in the present study
were allowed to develop for an additional 18±24 hr after anti-munoprecipitations revealed that some integrin subunits
were reduced after treatment with antisense but not re- sense treatment, it is likely that the b1 subunits had turned-
over completely by the time of analysis and were reconstitu-versed-sense oligonucleotides. The results suggest that inte-
grin a subunits are required for cranial neural crest cell ted, whereas the a subunits remained reduced.
The antisense oligonucleotide directed against the b1 sub-attachment and emigration.
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FIG. 3ÐContinued
unit of integrin reduced the amount of this protein, and its crest cell attachment selectively to ®bronectin (ha4-1, ha4-
2, and ra1-1). When injected into embryos, all of these oligo-associated a subunits, detectable on the surfaces of cells,
both in vitro and within the embryo by 6 hr after treatment. nucleotides perturbed normal neural crest cell migration
and caused defects in the neural tube. The ha4-1 oligonucle-A second antisense oligonucleotide (ha4-1) selectively re-
duced a 180-kDa protein band in b1 immunoprecipitates otide was designed using sequence information from mam-
malian a4 integrin, raising the possibility that this recog-from surface-labeled cranial neural crest cells. Because this
aON selectively inhibited neural crest cell attachment to nizes a chick a4 subunit. In fact, a4b1 is known to be a
®bronectin receptor in other species (Wayner et al., 1989).®bronectin, but not laminin, the heterodimer affected by
this aON may represent the primary ®bronectin receptor However, it must be noted that the antisense oligonucleo-
tides used in our study were selected based on nucleotideon this cell population.
Several antisense oligonucleotides reduced cranial neural sequence information from other species and do not neces-
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sarily correspond to the same a subunits in avian integrins One oligonucleotide tested (ha5) reduced cranial neural
crest cell attachment to both ®bronectin and laminin andfor which sequences are currently unavailable. Because of
species differences, the avian sequences may be somewhat perturbed cranial neural crest cell migration and neural tube
formation in vivo. Therefore, this oligonucleotide may rec-different than those in human and rat and may share some
short sequence similarity with heterologous a subunits in ognize a promiscuous receptor or a region common to two
integrin transcripts, one for ®bronectin and one for laminin.other species. Consequently, functional and biochemical
tests of the speci®city of these antisense oligonucleotides Oligonucleotide ha4-3 had no effect on cranial neural
crest cell attachment to ®bronectin or laminin but did affectmay be a more reliable assay for their subunit identi®cation.
The ha4-1 antisense oligonucleotide reduced several inte- neural tube formation and cranial neural crest cell migra-
tion. In our previous study, this oligonucleotide perturbedgrin bands in biotinylated cells from embryonic chick
heads. Therefore, we cannot rule out the possibility that a1b1 integrin-mediated attachment to laminin and reduced
the amount of detectable a1 integrin protein on the surfacethis oligonucleotide interacts with a number of other inte-
grins in addition to the 180-kDa subunit present on cranial of trunk neural crest cells (Lallier and Bronner-Fraser, 1993).
In contrast to the trunk, cranial neural crest cells do notneural crest cells. These subunits may be present within
the embryonic cranial tissue, but absent from neural crest possess detectable levels of the a1 integrin subunit on their
surfaces (Lallier and Bronner-Fraser, 1992). Several explana-cells. Support for this possibility comes from the ®nding
that this oligonucleotide reduces attachment of trunk neu- tions could account for the differential effects of this oligo-
nucleotide in vitro and in vivo. First, the ha4-3 oligonucleo-ral crest cells to laminin substrata and reduces the amount
of a1 integrin, a 165-kDa band, present on the surface of tide could affect an integrin on neural crest cells that does
not recognize ®bronectin or laminin. This receptor may aidthese cells (Lallier and Bronner-Fraser, 1993).
Two other oligonucleotides, ha4-2 and ra1-1, also re- in the attachment of cranial neural crest cells to other ECM
components, such as collagens or tenascin. Second, this oli-duced cranial neural crest cell attachment to ®bronectin
selectively. On trunk neural crest cells (Lallier and Bronner- gonucleotide may affect cells other than cranial neural crest
cells by altering levels of either a1b1 or other integrins. TheFraser, 1993), ha4-2 selectively reduced attachment to ®-
bronectin and reduced a 180-kDa protein on the surface of predominance of neural tube malformations (as opposed to
neural crest defects) in these embryos may indicate thatthese cells. Therefore, this oligonucleotide may be affecting
the same 180-kDa band as the ha4-1 antisense oligonucleo- the receptor affected by this oligonucleotide may be more
intimately involved with neural tube rather than neuraltide. The ra1-1 aON had no detectable effects on attach-
ment of trunk neural crest cells to any ECM component crest development.
The present ®ndings demonstrate the utility of using anti-tested (Lallier and Bronner-Fraser, 1993). Whether it recog-
nizes a distinct ®bronectin receptor from that inhibited by sense oligonucleotides as a means of selectively reducing
targeted molecules within developing embryos. By con-ha4-2 and ha4-1 on cranial neural crest cells has yet to be
determined. ®rming the selectivity of the in vivo perturbation with in
vitro functional and biochemical data, we have shown thatLaminin is thought to be important for neural crest cell
attachment in vitro (Newgreen and Thiery, 1980) and migra- antisense oligonucleotides are useful tools to dissect the
complex molecular interactions involved in neural crest mi-tion in vivo, since injection of the INO antibody (Bronner-
Fraser and Lallier, 1988), which recognizes a laminin±hep- gration. Although further study is required to identify the
exact nature of each a subunit involved, the data presentedaran sulfate proteoglycan complex (Matthew and Patterson,
1983), causes defects in cranial neural crest migration. In here indicate that it will be possible to perturb the function
of individual integrin subunits in vivo and to elucidate theirthe present studies, a single oligonucleotide (ra1-2) selec-
tively reduced cranial neural crest cell attachment to lami- role in neural crest cell migration and other physiologically
important processes.nin in vitro and also perturbed cranial neural crest cell mi-
gration when injected onto the migratory pathway in vivo.
Interestingly, this oligonucleotide had no effect on trunk
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